Scientists Report Ticks Carrying Pathogens Moving Into Canada From U.S.
Researchers say several tick species carrying disease-causing pathogens are advancing northward from the United States at a rate of about 50 kilometres per year. The lone star tick, already established in Maine, can transmit a pathogen that triggers severe red meat allergy in humans.
theyeshivaworld.comScientists report that multiple tick species carrying pathogens are moving northward from the northern United States into Canada at a rate of about 50 kilometres per year. Some of these ticks have already been spotted in Nova Scotia but have not yet established reproducing populations there. Government of Canada records show more than 40 tick species already present in the country.
The blacklegged tick, also known as the deer tick, is the best-known species already in Canada. It carries the bacteria responsible for Lyme disease, which can produce fever, fatigue and a bull's-eye rash. Untreated infections may lead to joint, heart and nervous system complications.
Of particular concern is the lone star tick, which is established in Maine. The species can transmit a pathogen that causes alpha-gal syndrome, a severe allergy to red meat. One gardener in Harpswell, Maine, described experiencing anaphylactic shock after eating beef, with symptoms including widespread hives, itching and progressive shortness of breath.
The Asian long-horned tick has also drawn attention in Nova Scotia. It has not established itself in the province, but some livestock producers are monitoring herds closely. The tick can cause anemia in cattle; if severe and untreated, it can result in death and financial losses for farmers.
A new tick research facility opened at Acadia University in Wolfville, Nova Scotia. The laboratory is currently raising American dog ticks using a machine that feeds them blood through synthetic skin designed to mimic human tissue. Last month researchers at the facility successfully reared one tick to maturity and observed it reproduce, marking a first for the laboratory.
The facility plans to import lone star ticks and other species under secure conditions for study. Officials at the laboratory said the work is intended to improve understanding of tick biology and support development of new repellent products and treatments.
They noted that no vaccine for Lyme disease is yet available and that some tick-borne illnesses, such as Powassan virus, lack specific treatments and can be fatal.
Public health guidance emphasizes basic precautions. These include tucking pant legs into socks when in wooded or grassy areas, performing regular tick checks after outdoor activity, and removing tall grass and vegetation along fence lines where ticks may quest for hosts.
Key Facts
Story Timeline
3 events- 2026
New tick research facility at Acadia University begins operations and successfully rears first tick to maturity.
1 sourceCbc - Recent
Lone star ticks spotted in Nova Scotia but not yet established.
1 sourceCbc - Ongoing
Multiple tick species advance north from U.S. at 50 km per year.
1 sourceCbc
Potential Impact
- 01
Public health agencies may expand Lyme disease awareness and prevention messaging in affected provinces.
- 02
Increased cases of alpha-gal syndrome may occur in Canadian regions where lone star ticks become established.
- 03
Livestock producers in Nova Scotia could face higher veterinary costs and animal losses from Asian long-horned ticks.
- 04
Research at the new Acadia facility could accelerate development of tick repellents or pathogen treatments.
Transparency Panel
Related Stories
NprWHO Director Visits Congo as Ebola Outbreak Spreads
The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.
medpagetoday.comFDA Panel Recommends XFG Variant for Fall Covid Shots
Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.
Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery
Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…